+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Alpha Emitters Market by Application, End User, Emitter Type, Equipment Type, Delivery Mode, Purity Grade, Detection Technique - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715680
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Alpha Emitters Market grew from USD 1.06 billion in 2024 to USD 1.28 billion in 2025. It is expected to continue growing at a CAGR of 20.29%, reaching USD 3.21 billion by 2030.

Pioneering the Next Era of Alpha Emitter Applications

Alpha-emitting isotopes have emerged as a pivotal technology across environmental monitoring, industrial testing, medical therapy, and advanced research initiatives. Their unique mode of delivering high-energy particles with minimal penetration depth underpins breakthroughs ranging from precise cancer treatments to robust material inspections. As governments tighten safety regulations and research institutions accelerate clinical trials, demand for refined alpha sources and sophisticated detection systems is escalating.

This report opens with a panoramic view of the alpha emitter ecosystem, spotlighting the drivers catalyzing innovation and adoption. From the escalating need for targeted alpha therapies in oncology to the expanding use of alpha-based sensors for air and water quality assessments, each application underscores the transformative potential of these isotopes. By delving into key market forces, regulatory dynamics, and supply chain complexities, this introduction sets the stage for a deep dive into the shifts and trends reshaping the industry, empowering stakeholders to navigate the evolving terrain with confidence.

Emerging Forces Redefining the Alpha Emitter Landscape

A convergence of technological breakthroughs and policy shifts is redefining the alpha emitter landscape. Advanced generator designs now yield higher purity grades, enabling precise dosimetry in targeted therapies and enhancing detection sensitivity in non-destructive testing. Simultaneously, regulatory bodies are imposing stringent quality and safety mandates, driving producers to adopt rigorous validation protocols and invest in automated quality assurance systems.

Parallel to these developments, collaborations between government agencies and private enterprises are unlocking new research avenues. Environmental agencies are integrating alpha sensors into large-scale monitoring networks, while hospitals are expanding clinical trials for targeted alpha therapies against resistant cancers. The intersection of these initiatives is fostering a vibrant innovation ecosystem, where cross-sector partnerships accelerate commercialization and elevate standards across the board.

Navigating the Ripple Effects of 2025 US Tariffs on Alpha Emitters

The introduction of United States tariffs on select alpha emitter materials in 2025 has set off a chain reaction across the global supply network. Producers reliant on imported precursor isotopes faced immediate cost escalations, prompting a strategic pivot toward domestic synthesis routes and forging alliances with alternative suppliers. These recalibrations have lengthened lead times for certain generator components, compelling end users to revise project timelines and inventory strategies.

Downstream, medical centers and research institutes absorbed part of the added expense, leading to a re-prioritization of clinical trial budgets and environmental monitoring initiatives. Some suppliers introduced bundled service models to offset price hikes, integrating equipment maintenance and rapid replenishment protocols within new contract frameworks. Ultimately, the tariff-driven environment has spurred a wave of supplier diversification, encouraging stakeholders to adopt multi-source procurement approaches and strengthening the sector’s resilience against future policy fluctuations.

Dissecting Alpha Emitter Market Through Multifaceted Segmentation

A granular segmentation of the market unveils nuanced opportunities and areas for growth. Examining applications reveals that environmental monitoring benefits from specialized air, soil and water sampling tools optimized for low-level alpha detection, while industrial testing harnesses non-destructive analysis and thickness gauging applications to ensure structural integrity in aerospace and manufacturing sectors. In medical therapy, pain palliation services and targeted alpha therapy are delivering unprecedented efficacy in oncology, supported by refined source encapsulation techniques. Meanwhile, clinical and preclinical research continues to expand the frontier of novel isotope uses.

Turning to end users, environmental agencies deploy field-adaptable sensor networks to track pollutant dispersion, hospitals and clinics integrate alpha therapy protocols alongside conventional regimens, industrial non-destructive testing providers adopt automated scanning platforms for quality assurance, and research institutes leverage bespoke isotope formulations for pioneering laboratory investigations. The landscape of emitter types further diversifies the market, with actinium-225 leading targeted therapies, americium-241 serving calibration and smoke detection needs, polonium-210 providing high-energy alpha emissions for specialized research, and radium-223 gaining traction in bone metastasis treatments.

Equipment type segmentation highlights the critical role of detectors, generators and sources. Gas-filled, scintillation and solid-state detectors deliver varying resolutions and operational profiles to match application demands. Cartridge and column generators offer flexible supply modalities for on-site isotope production, while sealed and unsealed sources cater to distinct handling and safety requirements. Delivery mode choices-from composite materials to liquid solutions featuring buffered or saline formulations, and electroplated or thin-film sealed sources-drive performance attributes tailored to specific workflows. Purity grades ranging from bulk to carrier-free and no-carrier-added standards ensure compatibility with stringent clinical protocols and high-precision research. Finally, detection techniques such as CdZnTe, HPGe, ionization chambers, NaI(Tl), plastic scintillators, proportional counters and solid-state detectors form a comprehensive toolkit for diverse measurement challenges.

Unearthing Insights Across Global Regions

Regional dynamics underscore the divergent trajectories shaping alpha emitter adoption worldwide. In the Americas, robust regulatory frameworks and established healthcare infrastructures drive early uptake of targeted alpha therapies, while environmental agencies in North America lead initiatives to integrate alpha detection into national pollutant monitoring systems. South American markets, buoyed by mining and oil exploration activities, leverage alpha-based thickness gauging to enhance operational safety and yield.

Europe, the Middle East and Africa present a tapestry of regulatory harmonization and market fragmentation. The European Union’s stringent radiopharmaceutical directives catalyze high-grade source production, whereas Middle Eastern nations prioritize strategic research partnerships to build domestic capabilities. In Africa, emerging research institutes focus on preclinical studies, supported by international collaborations that provide access to actinium-225 and radium-223.

Asia-Pacific exhibits the highest growth momentum, propelled by government-funded clinical trials and industrial modernization programs. China and India are scaling up generator manufacturing to reduce reliance on imports, while Japan and South Korea invest heavily in detection technology R&D. Across the region, increasing environmental awareness and public health initiatives are amplifying demand for alpha-based monitoring and therapeutic solutions.

Profiling Key Players Shaping the Alpha Emitter Domain

Several leading organizations are at the forefront of alpha emitter innovation. Specialized radiopharmaceutical firms engineer high-purity actinium-225 and radium-223 sources, collaborating with oncology centers to advance targeted therapy protocols. Companies with expertise in industrial instrumentation integrate scintillation and solid-state detector technologies into turnkey non-destructive testing solutions used across aerospace, automotive and energy sectors. Equipment manufacturers that excel in generator design optimize cartridge and column systems for seamless isotope production in clinical and research settings.

On the research front, dedicated isotope producers partner with national laboratories to scale polonium-210 synthesis, while academic spin-offs refine purification techniques to achieve carrier-free and no-carrier-added grades. Technology integrators focusing on environmental applications develop ruggedized sampling platforms and remote data analytics tools, enabling continuous monitoring of alpha-emitting contaminants in air, soil and water. These collaborations and cross-industry synergies are accelerating adoption curves and setting new benchmarks for quality and performance.

Strategic Recommendations for Industry Leadership in Alpha Emitters

Industry leaders should adopt a multifaceted strategy to secure competitive advantage. Investment in advanced purification and generator technologies will lower production costs and improve supply reliability, while diversifying application portfolios can mitigate risks associated with single-sector dependency. Strengthening collaborations with regulatory agencies and professional societies ensures early alignment with evolving safety standards, reducing time to market for new isotopic products.

Simultaneously, forging alliances with pharmaceutical developers accelerates clinical adoption of targeted alpha therapies, while partnerships with environmental agencies and industrial service providers open new revenue streams. Stakeholders must also prioritize integration of digital monitoring and maintenance frameworks to enhance operational efficiency and customer satisfaction. By combining technical excellence, regulatory foresight and strategic partnerships, organizations can navigate tariff volatility and capitalize on emerging market segments.

Methodological Rigor Underpinning This Analysis

This analysis draws upon a rigorous methodology combining primary interviews with industry experts, in-depth reviews of regulatory filings and academic publications, and comprehensive examination of patent landscapes. Data was triangulated through cross-validation with financial statements, trade data and technology performance benchmarks. Segmentation frameworks were applied to dissect the market by application, end user, emitter type, equipment, delivery mode, purity grade and detection technique, ensuring a holistic perspective.

Quality assurance protocols included iterative peer reviews and expert panel consultations, while regional insights were enriched through collaboration with local stakeholders in key markets. The integration of qualitative narratives with quantitative performance indicators underpins the robustness of the findings, delivering actionable intelligence that addresses both strategic and operational imperatives for decision-makers across the alpha emitter ecosystem.

Converging Insights Into a Unified Perspective

Collectively, the insights presented here converge to illustrate a market in the midst of transformative growth. Technological advances, regulatory realignments and shifting supply dynamics are creating both challenges and opportunities across the alpha emitter value chain. Stakeholders who grasp the nuances of segmentation, anticipate regional shifts and cultivate strategic partnerships will be best positioned to lead the next wave of innovation.

As the industry transitions toward higher purity standards, integrated digital frameworks and broader application scopes, agility and foresight will be critical. By leveraging the comprehensive analysis laid out in this report, organizations can align their investments, streamline operations and sustain competitive differentiation in an increasingly complex and dynamic market.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Environmental Monitoring
      • Air Monitoring
      • Soil Sampling
      • Water Monitoring
    • Industrial Testing
      • Non-Destructive Testing
      • Thickness Gauging
    • Medical Therapy
      • Pain Palliation
      • Targeted Alpha Therapy
    • Research & Development
      • Clinical Trials
      • Preclinical Research
  • End User
    • Environmental Agencies
    • Hospitals & Clinics
    • Industrial Non-Destructive Testing Providers
    • Research Institutes
  • Emitter Type
    • Actinium-225
    • Americium-241
    • Polonium-210
    • Radium-223
  • Equipment Type
    • Detectors
      • Gas-Filled Detectors
      • Scintillation Detectors
      • Solid State Detectors
    • Generators
      • Cartridge Generators
      • Column Generators
    • Sources
      • Sealed Sources
      • Unsealed Sources
  • Delivery Mode
    • Composite Materials
    • Liquid Solutions
      • Buffered Solutions
      • Saline Solutions
    • Sealed Sources
      • Electroplated Sources
      • Thin-Film Sources
  • Purity Grade
    • Bulk
    • Carrier-Free
    • No-Carrier-Added
  • Detection Technique
    • CdZnTe Detectors
    • HPGe Detectors
    • Ionization Chambers
    • NaI(Tl) Scintillators
    • Plastic Scintillators
    • Proportional Counters
    • Solid State Detectors
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Bayer AG
  • Novartis AG
  • Curium Pharma
  • Telix Pharmaceuticals Limited
  • RayzeBio, Inc.
  • Actinium Pharmaceuticals, Inc.
  • Nordic Nanovector ASA
  • Fusion Pharmaceuticals Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Alpha Emitters Market, by Application
8.1. Introduction
8.2. Environmental Monitoring
8.2.1. Air Monitoring
8.2.2. Soil Sampling
8.2.3. Water Monitoring
8.3. Industrial Testing
8.3.1. Non-Destructive Testing
8.3.2. Thickness Gauging
8.4. Medical Therapy
8.4.1. Pain Palliation
8.4.2. Targeted Alpha Therapy
8.5. Research & Development
8.5.1. Clinical Trials
8.5.2. Preclinical Research
9. Alpha Emitters Market, by End User
9.1. Introduction
9.2. Environmental Agencies
9.3. Hospitals & Clinics
9.4. Industrial Non-Destructive Testing Providers
9.5. Research Institutes
10. Alpha Emitters Market, by Emitter Type
10.1. Introduction
10.2. Actinium-225
10.3. Americium-241
10.4. Polonium-210
10.5. Radium-223
11. Alpha Emitters Market, by Equipment Type
11.1. Introduction
11.2. Detectors
11.2.1. Gas-Filled Detectors
11.2.2. Scintillation Detectors
11.2.3. Solid State Detectors
11.3. Generators
11.3.1. Cartridge Generators
11.3.2. Column Generators
11.4. Sources
11.4.1. Sealed Sources
11.4.2. Unsealed Sources
12. Alpha Emitters Market, by Delivery Mode
12.1. Introduction
12.2. Composite Materials
12.3. Liquid Solutions
12.3.1. Buffered Solutions
12.3.2. Saline Solutions
12.4. Sealed Sources
12.4.1. Electroplated Sources
12.4.2. Thin-Film Sources
13. Alpha Emitters Market, by Purity Grade
13.1. Introduction
13.2. Bulk
13.3. Carrier-Free
13.4. No-Carrier-Added
14. Alpha Emitters Market, by Detection Technique
14.1. Introduction
14.2. CdZnTe Detectors
14.3. HPGe Detectors
14.4. Ionization Chambers
14.5. NaI(Tl) Scintillators
14.6. Plastic Scintillators
14.7. Proportional Counters
14.8. Solid State Detectors
15. Americas Alpha Emitters Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Alpha Emitters Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Alpha Emitters Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Bayer AG
18.3.2. Novartis AG
18.3.3. Curium Pharma
18.3.4. Telix Pharmaceuticals Limited
18.3.5. RayzeBio, Inc.
18.3.6. Actinium Pharmaceuticals, Inc.
18.3.7. Nordic Nanovector ASA
18.3.8. Fusion Pharmaceuticals Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. ALPHA EMITTERS MARKET MULTI-CURRENCY
FIGURE 2. ALPHA EMITTERS MARKET MULTI-LANGUAGE
FIGURE 3. ALPHA EMITTERS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ALPHA EMITTERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ALPHA EMITTERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ALPHA EMITTERS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ALPHA EMITTERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ALPHA EMITTERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. ALPHA EMITTERS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ALPHA EMITTERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ALPHA EMITTERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ALPHA EMITTERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AIR MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOIL SAMPLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ALPHA EMITTERS MARKET SIZE, BY WATER MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THICKNESS GAUGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PAIN PALLIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ALPHA EMITTERS MARKET SIZE, BY TARGETED ALPHA THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL NON-DESTRUCTIVE TESTING PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ACTINIUM-225, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AMERICIUM-241, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ALPHA EMITTERS MARKET SIZE, BY POLONIUM-210, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RADIUM-223, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GAS-FILLED DETECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SCINTILLATION DETECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARTRIDGE GENERATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COLUMN GENERATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ALPHA EMITTERS MARKET SIZE, BY UNSEALED SOURCES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COMPOSITE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BUFFERED SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SALINE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ELECTROPLATED SOURCES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THIN-FILM SOURCES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BULK, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARRIER-FREE, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NO-CARRIER-ADDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CDZNTE DETECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HPGE DETECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL ALPHA EMITTERS MARKET SIZE, BY IONIZATION CHAMBERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NAI(TL) SCINTILLATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PLASTIC SCINTILLATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PROPORTIONAL COUNTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES ALPHA EMITTERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 104. CANADA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. CANADA ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 106. CANADA ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 107. CANADA ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 108. CANADA ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 109. CANADA ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. CANADA ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 111. CANADA ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 112. CANADA ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 113. CANADA ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 114. CANADA ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 115. CANADA ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 116. CANADA ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 117. CANADA ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 118. CANADA ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 119. CANADA ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 120. MEXICO ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. MEXICO ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 122. MEXICO ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 123. MEXICO ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 124. MEXICO ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 125. MEXICO ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. MEXICO ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 127. MEXICO ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 128. MEXICO ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 129. MEXICO ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 130. MEXICO ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 131. MEXICO ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 132. MEXICO ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 133. MEXICO ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 134. MEXICO ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 135. MEXICO ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 201. GERMANY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. GERMANY ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 203. GERMANY ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 204. GERMANY ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 205. GERMANY ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 206. GERMANY ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. GERMANY ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 208. GERMANY ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 209. GERMANY ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 210. GERMANY ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 211. GERMANY ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 212. GERMANY ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 213. GERMANY ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 214. GERMANY ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 215. GERMANY ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 216. GERMANY ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 217. FRANCE ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. FRANCE ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 219. FRANCE ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 220. FRANCE ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 221. FRANCE ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 222. FRANCE ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. FRANCE ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 224. FRANCE ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 225. FRANCE ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 226. FRANCE ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 227. FRANCE ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 228. FRANCE ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 229. FRANCE ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 230. FRANCE ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 231. FRANCE ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 232. FRANCE ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 243. RUSSIA ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 244. RUSSIA ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 245. RUSSIA ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 246. RUSSIA ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 247. RUSSIA ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 248. RUSSIA ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 249. ITALY ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. ITALY ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 251. ITALY ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 252. ITALY ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 253. ITALY ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 254. ITALY ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. ITALY ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 256. ITALY ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 257. ITALY ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 258. ITALY ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 259. ITALY ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 260. ITALY ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 261. ITALY ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 262. ITALY ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 263. ITALY ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 264. ITALY ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 265. SPAIN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. SPAIN ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 267. SPAIN ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 268. SPAIN ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 269. SPAIN ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 270. SPAIN ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. SPAIN ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 272. SPAIN ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 273. SPAIN ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 274. SPAIN ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 275. SPAIN ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 276. SPAIN ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 277. SPAIN ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 278. SPAIN ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 279. SPAIN ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 280. SPAIN ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 300. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 302. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 304. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 324. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 326. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 328. SOUTH AFRICA ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 329. DENMARK ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 330. DENMARK ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 331. DENMARK ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 332. DENMARK ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 333. DENMARK ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 334. DENMARK ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 335. DENMARK ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2030 (USD MILLION)
TABLE 336. DENMARK ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2030 (USD MILLION)
TABLE 337. DENMARK ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 338. DENMARK ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2030 (USD MILLION)
TABLE 339. DENMARK ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2030 (USD MILLION)
TABLE 340. DENMARK ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 341. DENMARK ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 342. DENMARK ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2030 (USD MILLION)
TABLE 343. DENMARK ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 344. DENMARK ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 345. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 346. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2030 (USD MILLION)
TABLE 347. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
TABLE 348. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 349. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 350. NETHERLANDS ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLIO

Companies Mentioned

The companies profiled in this Alpha Emitters market report include:
  • Bayer AG
  • Novartis AG
  • Curium Pharma
  • Telix Pharmaceuticals Limited
  • RayzeBio, Inc.
  • Actinium Pharmaceuticals, Inc.
  • Nordic Nanovector ASA
  • Fusion Pharmaceuticals Inc.

Methodology

Loading
LOADING...

Table Information